New rabies vaccine trial aims to shield thousands from deadly virus
NCT ID NCT07500207
First seen Apr 07, 2026 · Last updated May 21, 2026 · Updated 6 times
Summary
This study tests a new rabies vaccine in 3,000 healthy people aged 10 to 60. The goal is to see if the vaccine triggers strong antibodies to prevent rabies after a possible exposure. Participants receive different shot schedules, and researchers check blood for immune response and watch for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RABIES PREVENTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
sichuan CDC
Neijiang, Sichuan, China
Conditions
Explore the condition pages connected to this study.